Sign up to save your podcasts
Or
Share Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data and shares clinical investigator perspectives on the role of TROP2-directed antibody-drug conjugates in the management of HR-positive and triple-negative breast cancers.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6262 ratings
Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data and shares clinical investigator perspectives on the role of TROP2-directed antibody-drug conjugates in the management of HR-positive and triple-negative breast cancers.
CME information and select publications here.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
139 Listeners
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
14 Listeners
Gynecologic Oncology Update
13 Listeners
Hematologic Oncology Update
71 Listeners
Dermatologic Oncology Update
0 Listeners
NEJM This Week
322 Listeners
Research To Practice | Oncology Videos
111 Listeners
JAMA Clinical Reviews
507 Listeners
ASCO Daily News
61 Listeners
Mayo Clinic Talks
282 Listeners
The Curbsiders Internal Medicine Podcast
3,338 Listeners
The ONS Podcast
195 Listeners
The Clinical Problem Solvers
516 Listeners
Oncology Today with Dr Neil Love
60 Listeners
Two Onc Docs
181 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners